“Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.”
AUTHORS: Tzoneva G*, Perez-Garcia A*, Carpenter Z*, Khiabanian H, Tosello V, Allegretta M, Paietta E, Racevskis J, Rowe J, Tallman M, Paganin M, Basso G, Hof J, Kirschner-Schwabe R, Palomero T‡, Rabadan R‡, Ferrando A.‡
* These authors have contributed equally to this work. ‡ These authors have contributed equally to this work.